{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:08Z","timestamp":1790094608050,"version":"4.0.1"},"reference-count":60,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Development and Technology"],"published-print":{"date-parts":[[2023,11,26]]},"DOI":"10.1080\/10837450.2023.2274394","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:01:51Z","timestamp":1699027311000},"page":"915-927","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["<i>In vitro<\/i>\n            evaluation and\n            <i>in\u00a0vivo<\/i>\n            efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma"],"prefix":"10.1080","volume":"28","author":[{"given":"Mine","family":"Diril","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemal Volkan","family":"\u00d6zdokur","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Arts and Sciences, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Sciences, Ege University, Izmir, Turkey"},{"name":"Center for Drug R&amp;D and Pharmacokinetic Applications (ARGEFAR), Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Ye\u015fim","family":"Karasulu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym14050925"},{"key":"e_1_3_3_3_1","unstructured":"Alves ADC. 2017. Development of a proliposome formulation as a drug carrier for a novel antitumor drug."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioy259"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13098"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/08982101003735970"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112841"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.04.013"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b01142"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00677"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205074"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S130404"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b07218"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-015-1351-1"},{"issue":"2014","key":"e_1_3_3_15_1","first-page":"33","article-title":"A simple and sensitive hplc method for fluorescence quantitation of doxorubicin in micro-volume plasma\u202f: applications to Pharmacokinetic Studies in Rats","volume":"14","author":"Daeihamed M","year":"2015","unstructured":"Daeihamed M, Haeri A, Dadashzadeh S. 2015. A simple and sensitive hplc method for fluorescence quantitation of doxorubicin in micro-volume plasma\u202f: applications to Pharmacokinetic Studies in Rats. Iran J Pharm Res. 14(December 2014):33\u201342.","journal-title":"Iran J Pharm Res"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2008.11928410"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-016-0012-4"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567201816666190820143957"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8467169"},{"key":"e_1_3_3_20_1","unstructured":"FDA. 2018. Draft guidance on doxorubicin hydrochloride. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM199635.pdf."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.05.028"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2112997"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Guoqin N Brian C Jeffrey H. 2010. Preparation and Characterization of Doxorubicin Liposomes.: 211\u2013219.","DOI":"10.1007\/978-1-60761-609-2_14"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2017.1304403"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2017.1304403"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2015.12.005"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.093849"},{"key":"e_1_3_3_28_1","unstructured":"ICH Topic Q 1 A (R2). 2006. Stability Testing of New Drug Substances and Products."},{"key":"e_1_3_3_29_1","unstructured":"ICH. 2022. ICH guideline Q2(R2) on validation of analytical procedures."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00766-3"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc900323v.In"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1GC02251B"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jmi.12392"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.744811"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.4103\/2394-5079.167439"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111048"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.09.020"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7439.1000448"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071021"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Radu ER Semenescu A Voicu SI. 2022. Recent advances in stimuli \u2011 responsive doxorubicin delivery systems for liver cancer therapy.","DOI":"10.3390\/polym14235249"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms12074414"},{"issue":"4","key":"e_1_3_3_43_1","first-page":"309","article-title":"Liposomes as drug delivery system: A brief review","volume":"5","author":"Sen R","year":"2014","unstructured":"Sen R, Sahoo SK, Satpathy S. 2014. Liposomes as drug delivery system: A brief review. Int J Res Pharm Sci. 5(4):309\u2013321.","journal-title":"Int J Res Pharm Sci"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2014.954582"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Smits EAW Vromans H Pieters EHE Smits CJP Wijs-Rot ND. 2018. The availability of drug by liposomal drug delivery.","DOI":"10.1007\/s10637-018-0708-4"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1366\/000370209788964557"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061775"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/2211068214561025"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Stone WL Mu S Smith M Salil KD. Therapeutic uses of antioxidant liposomes. Mol Biotechnol. 27:217\u2013230.","DOI":"10.1385\/MB:27:3:217"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2017.03.024"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/152474"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S209325"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.15436\/2377-1372.16.1139"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00004"},{"key":"e_1_3_3_55_1","unstructured":"Trevisan J Cavalcanti L Oliveira C. 2011. Technological Aspects of Scalable Processes for the Production of Functional Liposomes for Gene Therapy. p. 267\u2013298."},{"key":"e_1_3_3_56_1","unstructured":"World Health Organization. 2022. Number of new cases and deaths from liver cancer predicted to rise by more than 55% by 2040."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110682"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2013.12.002.Doxorubicin"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.07.182"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.11.045"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7439.1000519.Advances"}],"container-title":["Pharmaceutical Development and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2023.2274394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:13:57Z","timestamp":1727187237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10837450.2023.2274394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,11,26]]}},"alternative-id":["10.1080\/10837450.2023.2274394"],"URL":"https:\/\/doi.org\/10.1080\/10837450.2023.2274394","relation":{},"ISSN":["1083-7450","1097-9867"],"issn-type":[{"value":"1083-7450","type":"print"},{"value":"1097-9867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}